EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 37 / No 10 (Octobre 2021) Med Sci (Paris), 37 10 (2021) 927-932 References
Open Access
Issue
Med Sci (Paris)
Volume 37, Number 10, Octobre 2021
Page(s) 927 - 932
Section Repères
DOI https://doi.org/10.1051/medsci/2021118
Published online 14 October 2021
  1. EcoU. Vertige de la liste. Paris: Flammarion, 2009 : 408 p [Google Scholar]
  2. Depraz N, Varela F, Vermesch P (eds). À l’épreuve de l’expérience : pour une pratique phénoménologique. Bucarest : Zeta Books; 2011 : 464 p. [Google Scholar]
  3. Le Breton D. La chair à vif. Usage médicaux et mondains du corps humain. Paris : Métaillé, 1993 : 336 p. [Google Scholar]
  4. BichatX. Traité des membranes. Paris: Hachette BNF, 2016 : 396 p [Google Scholar]
  5. PinelP. Nosographie philosophique ou la méthode d’analyse appliquée à la médecine. Paris: Hachette BNF, 2019 : 364. [Google Scholar]
  6. BernardC. Introduction à l’étude de la médecine expérimentale. Paris: Flammarion, 2013 : 384 p [Google Scholar]
  7. DescartesR. Méditations Métaphysiques. Paris: Le Livre de Poche, 1990 : 320 p [Google Scholar]
  8. DougadosM. Critères diagnostiques versus critères de classification. Définition et principes. Rev Rhum Monogr 2010 ; 77 : 3–6. [Google Scholar]
  9. AdamPHerzlichC. Sociologie de la médecine et de la maladie. Paris: Nathan, 1994 : 128 p. [Google Scholar]
  10. FoucaultM. Naissance de la clinique. Paris: PUF, 2015 : 300 p [Google Scholar]
  11. SackettDLRosenbergWMGrayJAet al. Evidence based medicine: what it is and what it isn’t. BMJ 1996 ; 312 : 71–72. [CrossRef] [PubMed] [Google Scholar]
  12. MariampillaiKGrangerBAmelinDet al. Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol 2018 ; 1 : 1528–1537. [Google Scholar]
  13. CarapitoRCarapitoCMorlonAet al. Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency. Ann Rheum Dis 2018 ; 77 : 1675–1687. [CrossRef] [PubMed] [Google Scholar]
  14. ProtheroeAEdwardsJCSimmonsAet al. Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin’s lymphoma. Rheumatology 1999 ; 38 : 1150–1152. [CrossRef] [PubMed] [Google Scholar]
  15. SpielmannLNespolaBSéveracFet al. Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes. Ann Rheum Dis 2019 ; 78 : 1101–1106. [CrossRef] [PubMed] [Google Scholar]
  16. LeCanguilhem G. Normal et le pathologique. Paris: PUF, 1996. [Google Scholar]
  17. StebbinsR. Career : the subjective approach, sociological quarterly. Sociol Quarterly 1970 ; 11 : 32–49. [CrossRef] [Google Scholar]
  18. PanushRSEdwardsLLongleySWebsterERhupus syndrome. Arch Intern Med 1988 ; 148 : 1633–1636. [CrossRef] [PubMed] [Google Scholar]
  19. ChamotAMBenhamouCLet al. Le syndrome acné pustulose hyperostose ostéite (SAPHO). Résultat d’une enquête nationale. Rev Rhum 1987 ; 54 : 187–196. [Google Scholar]
  20. BoutinRDResnickDThe SAPHO syndrome an evolving concept for unifying several idiopathic disorders of bone and skin. Am J Roentgenol 1998 ; 170 : 585–591. [CrossRef] [Google Scholar]
  21. KahnMFChamotAMSAPHO syndrome. Rheum Dis Clin North Am 1992 ; 18 : 225–246. [CrossRef] [PubMed] [Google Scholar]
  22. KuoCFGraingeMJMallenCet al. Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann Rheum 2016 ; 75 : 210–217. [CrossRef] [Google Scholar]
  23. FrallonardoPRamondaRPeruzzoLet al. Basic calcium phosphate and pyrophosphate crystals in early and late osteoarthritis: relationship with clinical indices and inflammation. Clin Rheumatol 2018 ; 37 : 2847–2853. [CrossRef] [PubMed] [Google Scholar]
  24. KahnMFFrontières et confins du rhumatisme psoriasique. Rev Rhum 2002 ; 69 : 682–684. [CrossRef] [Google Scholar]
  25. NeogiTJansenTLDalbethNet al. Gout classification criteria: an American college of rheumatology/european league against rheumatism collaborative initiative. Ann Rheum Dis 2015 ; 74 : 1789–1798. [CrossRef] [PubMed] [Google Scholar]
  26. TaylorWHelliwellPSGladmanDet al. A validation current classification criteria for the diagnosis of psoriatic arthritis. Ann Rheum Dis 2005 ; 64 : 107. [Google Scholar]
  27. De MassonABouazizJDBattistellaMet al. Immunopathologie du psoriasis : from bench to bedside. Med Sci (Paris) 2016 ; 32 : 253–259. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  28. López-ReyesAHernández-DíazCHofmannFPinedaCGout mimicking psoriatic arthritis flare. J Clin Rheumatol 2012 ; 18 : 220. [CrossRef] [PubMed] [Google Scholar]
  29. TsurutaNImafukuSNarisawaYHyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients. J Dermatol 2017 ; 44 : 1349–1352. [CrossRef] [PubMed] [Google Scholar]
  30. MerolaJFWuSHanJet al. Psoriasis, psoriatic arthritis, and risk of gout in US men and women. Ann Rheum Dis 2015 ; 74 : 1495–1500. [CrossRef] [PubMed] [Google Scholar]
  31. Felten R, Duret P.M., Gottenberg J.E., et al. At the crossroads of gout and psoriatic arthritis: psout. Clin Rheumatol 2020; 39 : 1405–13. [CrossRef] [PubMed] [Google Scholar]
  32. AridaDSilvaLSkareTLThe hypouricemiant effect of leflunomide. Joint Bone Spine 2014 ; 81 : 273–274. [CrossRef] [PubMed] [Google Scholar]
  33. MorinE. Introduction à la pensée complexe. Paris: Le Livre de Poche, 2014 : 160 p. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.